DYNE THERAPEUTICS INC (DYN:NASDAQ)
$20.41 0.5 (2.5113%)
Analysed DYNE THERAPEUTICS INC (DYN:NASDAQ) News Sources
Could Dyne Therapeutics’ (DYN) AMCP Spotlight Reveal How New FDA Leadership May Shape Its Pipeline?
15-04-2026
yahoo.com
Dyne Therapeutics Announces Participation at 2026 Academy of Managed Care Pharmacy (AMCP) Conference to Begin Shaping Access in US for Potential Neuromuscular Medicines
01-04-2026
yahoo.com
Clearbridge Small Cap Growth Strategy Added Dyne Therapeutics (DYN) in Q4
27-03-2026
yahoo.com
This Biotech Was Quietly Bought Before a $58 Per Share Takeout
21-03-2026
fool.com
Dyne Therapeutics Targets 2026 “Breakout Year” With DMD BLA Plans and DM1 Milestones at Stifel Conference
19-03-2026
marketbeat.com
Dyne Therapeutics Advances Rare Disease Pipeline With Pivotal Trials And Data
14-03-2026
yahoo.com
Dyne Therapeutics (DYN) Shares Key Details For Pivotal. Drugs
13-03-2026
yahoo.com
Dyne Therapeutics (DYN) Climbs 11.8% on Triple-Digit Price Target Upgrade
11-03-2026
yahoo.com
Dyne Therapeutics Announces Initiation of Phase 3 HARMONIA Trial of Z-Basivarsen in Myotonic Dystrophy Type 1 (DM1)
08-03-2026
yahoo.com
Dyne Therapeutics Announces New Positive Cardiopulmonary Results from DELIVER Trial of Z-Rostudirsen in Duchenne Muscular Dystrophy (DMD)
08-03-2026
yahoo.com
What is the current price of DYNE THERAPEUTICS INC (DYN:NASDAQ)?
The current price of DYNE THERAPEUTICS INC (DYN:NASDAQ) is $20.41.
DYNE THERAPEUTICS INC (DYN:NASDAQ) absolute price change since previous trading day?
The absolute price change of DYNE THERAPEUTICS INC (DYN:NASDAQ) since the previous trading day is $0.5.
DYNE THERAPEUTICS INC (DYN:NASDAQ) percentage price change since previous trading day?
The percentage price change of DYNE THERAPEUTICS INC (DYN:NASDAQ) since the previous trading day is 2.5113%.
What is the most recent average sentiment score for DYNE THERAPEUTICS INC (DYN:NASDAQ)?
The most recent average sentiment score for DYNE THERAPEUTICS INC (DYN:NASDAQ) is 88 out of 100.
What is the most recent average sentiment for DYNE THERAPEUTICS INC (DYN:NASDAQ)?
The most recent sentiment for DYNE THERAPEUTICS INC (DYN:NASDAQ) is .
SEC-8K** Filing Available For DYNE THERAPEUTICS INC (DYN:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.